Electroanalysis of Cytochrome P450 3A4 Catalytic Properties with Nanostructured Electrodes: The Influence of Vitamin B Group on Diclofenac Metabolism

about

Electroanalysis of Cytochrome P450 3A4 Catalytic Properties with Nanostructured Electrodes: The Influence of Vitamin B Group on Diclofenac Metabolism

Item

http://www.wikidata.org/entity/Q58873968

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в травні 2011

@uk

name

Electroanalysis of Cytochrome ...... Group on Diclofenac Metabolism

@en

Electroanalysis of Cytochrome ...... Group on Diclofenac Metabolism

@nl

type

Item

label

Electroanalysis of Cytochrome ...... Group on Diclofenac Metabolism

@en

Electroanalysis of Cytochrome ...... Group on Diclofenac Metabolism

@nl

prefLabel

Electroanalysis of Cytochrome ...... Group on Diclofenac Metabolism

@en

Electroanalysis of Cytochrome ...... Group on Diclofenac Metabolism

@nl

P1476

Electroanalysis of Cytochrome ...... Group on Diclofenac Metabolism

@en

P2093

Alexander I. Archakov

http://www.w3.org/2001/XMLSchema#string

Anna A. Makhova

http://www.w3.org/2001/XMLSchema#string

Evgeniya V. Shich

http://www.w3.org/2001/XMLSchema#string

Galina V. Ramenskaya

http://www.w3.org/2001/XMLSchema#string

Oksana S. Sizova

http://www.w3.org/2001/XMLSchema#string

Sergei A. Usanov

http://www.w3.org/2001/XMLSchema#string

Tatyana V. Bulko

http://www.w3.org/2001/XMLSchema#string

Victoria V. Shumyantseva

http://www.w3.org/2001/XMLSchema#string

Vladimir G. Kukes

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways

Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.

The metabolism of diclofenac--enzymology and toxicology perspectives.

Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring.

Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in vivo information.

Drug interactions evaluation: an integrated part of risk assessment of therapeutics.

Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line.

Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date.

Renal impairment associated with non-steroidal anti-inflammatory drugs.

Electrochemical investigations of cytochrome P450.

P2888

s12668-011-0007-4

P304

46-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12668-011-0007-4

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

vitamin B

diclofenac

vitamin